Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The Impact of Baseline A1c
Response to Retnakaran et al.
- Ian Blumer, MD, FRCP(C)
- From the Charles H. Best Diabetes Centre for Children and Youth, Whitby, Ontario, Canada; and the Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
- Address correspondence to Ian Blumer, MD, 401-95 Bayly St. West, Ajax, ON L1S 7K8, Canada. E-mail: ian{at}ianblumer.com
Retnakaran et al.’s (1) recent pooled analysis showed improved glycemic control (when using rapid-acting insulin analogs) with continuous subcutaneous insulin infusion (CSII) therapy compared with multiple daily …
